Sonoma Pharmaceuticals Inc (SNOA.OQ)
3.88USD
20 Apr 2018
$0.05 (+1.31%)
$3.83
$3.81
$3.95
$3.81
5,972
19,894
$7.75
$3.50
Latest Key Developments (Source: Significant Developments)
Sonoma Pharma Gets Three New UAE Regulatory Approvals
Jan 9 (Reuters) - Sonoma Pharmaceuticals Inc
Sonoma Pharmaceuticals announces second FDA approval to add antimicrobial language to alevicyn gel products
Dec 5 (Reuters) - Sonoma Pharmaceuticals Inc
Sonoma Pharmaceuticals announces FDA approval of expanded indication for Alevicyn
Nov 16 (Reuters) - Sonoma Pharmaceuticals Inc
Sonoma Pharmaceuticals posts Q2 loss $0.67/shr from continuing operations
Nov 9 (Reuters) - Sonoma Pharmaceuticals Inc
Sonoma Pharmaceuticals receives Brazilian approvals
Oct 31 (Reuters) - Sonoma Pharmaceuticals Inc
Oculus Innovative sciences Q1 revenue $3.8 million versus $3.7 million
Oculus Innovative Sciences Inc
Oculus Innovative Sciences says Q4 revenue fell 11 pct to $3.5 mln
Oculus Innovative Sciences Inc
BRIEF-Sonoma Pharma Receives Four New Uae Regulatory Approvals That Include Acne And Anti-Fungal Products
* SONOMA PHARMACEUTICALS RECEIVES FOUR NEW UAE REGULATORY APPROVALS THAT INCLUDE ACNE AND ANTI-FUNGAL PRODUCTS